214
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Radioprotective effect of mistletoe extract on intestinal toxicity: in vivo study using adult zebrafish

, , , , & ORCID Icon
Pages 845-852 | Received 02 Nov 2021, Accepted 03 Sep 2022, Published online: 07 Nov 2022

References

  • Abnoba G. Recommendations for use, Abnoba Viscum. [assessed July 1, 2018]. http://www.anthromed.org/UploadedDocuments/Abnoba%20Viscum.pdf.
  • Andreyev J. 2005. Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut. 54(8):1051–1054.
  • Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM. 2002. The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 52(1):176–183.
  • Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, Ten Haken RK, Yorke ED. 2010. Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 76(3):S3–S9.
  • Bonamin LV, de Carvalho AC, Waisse S. 2017. Viscum album (L.) in experimental animal tumors: a meta-analysis. Exp Ther Med. 13(6):2723–2740.
  • Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, et al. 2000. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 18(19):3339–3345.
  • Daroczi B, Kari G, McAleer MF, Wolf JC, Rodeck U, Dicker AP. 2006. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res. 12(23):7086–7091.
  • Ferreira MR, Muls A, Dearnaley DP, Andreyev HJ. 2014. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncol. 15(3):e139–e147.
  • Geiger GA, Parker SE, Beothy AP, Tucker JA, Mullins MC, Kao GD. 2006. Zebrafish as a “biosensor”? Effects of ionizing radiation and amifostine on embryonic viability and development. Cancer Res. 66(16):8172–8181.
  • Gruber S, Dörr W. 2016. Tissue reactions to ionizing radiation—oral mucosa. Mutat Res Rev Mutat Res. 770(Pt B):292–298.
  • Hall EJ, Giaccia AJ. 2006. Radiobiology for the radiologist. Philadelphia (PA): Lippincott Williams & Wilkins.
  • Halperin EC, Brady LW, Perez CA, Wazer DE. 2013. Perez & Brady’s principles and practice of radiation oncology. Philadelphia (PA): Lippincott Williams & Wilkins.
  • Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L, et al. 2013. The zebrafish reference genome sequence and its relationship to the human genome. Nature. 496(7446):498–503.
  • Huscher A, Bignardi M, Magri E, Vitali E, Pasinetti N, Costa L, Frata P, Magrini SM. 2009. Determinants of small bowel toxicity in postoperative pelvic irradiation for gynaecological malignancies. Anticancer Res. 29(11):4821–4826.
  • Kienle GS, Kiene H. 2007. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res. 12(3):103–119.
  • Kim DY, Park W, Lim DH, Lee JH, Yoo BC, Paik SW, Kho KC, Kim TH, Ahn YC, Huh SJ. 2005. Three‐dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma. Cancer. 103(11):2419–2426.
  • Koukourakis MI, Maltezos E. 2006. Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases. Anticancer Drugs. 17(2):133–138.
  • Lee HA, Park S, Seo YS, Yoon WS, Rim CH, Group KLCS. 2021. Benefits of local treatment including external radiotherapy for hepatocellular carcinoma with portal invasion. Biology. 10(4):326.
  • Lee J, Yoon WS, Koom WS, Rim CH. 2019. Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review. Strahlenther Onkol. 195(2):93–102.
  • Lodde M, Palermo S, Comploj E, Signorello D, Mian C, Lusuardi L, Longhi E, Zanon P, Mian M, Pycha A. 2005. Four years experience in bladder preserving management for muscle invasive bladder cancer. Eur Urol. 47(6):773–779.
  • McAleer MF, Davidson C, Davidson WR, Yentzer B, Farber SA, Rodeck U, Dicker AP. 2005. Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers. Int J Radiat Oncol Biol Phys. 61(1):10–13.
  • Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. 2002. Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 54(1):150–155.
  • Pelzer F, Loef M, Martin DD, Baumgartner S. 2022. Cancer-related fatigue in patients treated with mistletoe extracts: a systematic review and meta-analysis. Support Care Cancer. 30(8):6405–6418.
  • Pelzer F, Tröger W, Nat DR. 2018. Complementary treatment with mistletoe extracts during chemotherapy: safety, neutropenia, fever, and quality of life assessed in a randomized study. J Altern Complement Med. 24(9–10):954–961.
  • Potten CS. 2004. Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res. 161(2):123–136.
  • Rim CH, Kim CY, Yang DS, Yoon WS. 2018a. Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic review. Radiother Oncol. 129(1):112–122.
  • Rim CH, Kim CY, Yang DS, Yoon WS. 2018b. External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: a meta-analysis and systemic review. Radiother Oncol. 129(1):123–129.
  • Rim CH, Koun S, Park HC, Lee S, Kim CY. 2019. Radioprotective effects of mistletoe extract in zebrafish embryos in vivo. Int J Radiat Biol. 95(8):1150–1159.
  • Rim CH, Yang DS, Park YJ, Yoon WS, Lee JA, Kim CY. 2012. Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis. Jpn J Clin Oncol. 42(8):721–729.
  • Rim CH, Yim HJ, Park S, Seong J. 2019. Recent clinical applications of external beam radiotherapy for hepatocellular carcinoma according to guidelines, major trials and meta-analyses. J Med Imaging Radiat Oncol. 63(6):812–821.
  • Rim CH, Yoon WS. 2018. Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials. Onco Targets Ther. 11:2865–2874.
  • Sternemann M, Wiegel T, Geilen C, Orfanos C, Hinkelbein W. 2006. Skin and other reactions to radiotherapy–clinical presentation and radiobiology of skin reactions. Controvers Treat Skin Neoplasias. 39:96.
  • Traver D, Herbomel P, Patton EE, Murphey RD, Yoder JA, Litman GW, Catic A, Amemiya CT, Zon LI, Trede NS. 2003. The zebrafish as a model organism to study development of the immune system. Adv Immunol. 81:253–330.
  • Traver D, Winzeler A, Stern HM, Mayhall EA, Langenau DM, Kutok JL, Look AT, Zon LI. 2004. Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation. Blood. 104(5):1298–1305.
  • Yahyapour R, Amini P, Rezapour S, Cheki M, Rezaeyan A, Farhood B, Shabeeb D, Musa AE, Fallah H, Najafi M. 2018. Radiation-induced inflammation and autoimmune diseases. Mil Med Res. 5(1):9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.